Implementation of a High-Value, Evidence-Based Care Program: Impact and Opportunities for Learning Organizations

被引:0
|
作者
Williams, Stephen B. [1 ]
Mccaffrey, Peter [1 ]
Reynoso, David [1 ]
Keiser, Phillip [1 ]
Trevino, Rick [1 ]
Heymann, John [1 ]
Doulatram, Gulshan [1 ]
Deanda, Abe [1 ]
Harlin, Timothy J. [1 ]
Sharma, Gulshan [1 ]
机构
[1] Univ Texas Med Branch, Galveston, TX 77555 USA
关键词
D O I
10.1097/JHM-D-23-00099
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Goal:Value-based care is not simply a matter of cost, but also one of outcomes and harms per dollar spent. This definition encompasses three key components: healthcare delivery that is organized around patients' medical conditions, costs and outcomes that are actively and consistently measured, and information technology that enables the other two components. Our objective in this project was to implement and measure a systemwide high-value, evidence-based care initiative with five pillars of high-value practices.Methods:We performed a quasi-experimental study from September 1, 2019, to August 31, 2022, of a new care program at the University of Texas Medical Branch. Drawing from the ABIM Foundation's Choosing Wisely Campaign, the program was based on five pillars-blood management and antimicrobial, laboratory, imaging, and opioid stewardship-with interdisciplinary teams led by institutional subject matter experts (i.e., administrative leaders) accompanied by nursing, information technology, pharmacy, and clinical and nonclinical personnel including faculty and trainees. Each pillar addressed two goals with targeted interventions to assess improvements during the first three fiscal years (FYs) of implementation. The targets were set at 10% improvement by the end of each FY. Monthly measurements were recorded for each FY.Principal Findings:We tracked performance toward 30 pillar goals and determined that the teams were successful in 50%, 50%, and 70% of their goals for FY 2020, 2021, and 2022, respectively. For example, in the antimicrobial stewardship FY 2021 pillar, one goal was to decrease meropenem days of therapy (DOT) by 10% (baseline was 45 DOT/1,000 patient days; the target was 40.5 DOT/1,000 patient days). We measured quarterly DOT/1,000 patient day rates of 32.02, 30.57, and 26.9, respectively, for a cumulative rate of 26.9. Critical interventions included engaging and empowering providers and service lines (including outliers whose performance was outside norms), educational conferences, and transparent data analyses.Practical Applications:We showed that a multidisciplinary approach to the implementation of an evidence-based, high-value care program through a partnership of engaged administrative leaders, providers, and trainees can result in sustainable and measurable high-value healthcare delivery. Specifically, structuring the program with pillars to address defined metrics resulted in progressive improvement in meeting value-based goals at the University of Texas Medical Branch. Also, challenges can be embraced as learning opportunities to inform value-based interventions that range from technological to educational tactics. The results at the University of Texas Medical Branch provide a benchmark for the implementation of a program that engages, empowers, and aligns innovative value-based care initiatives.
引用
收藏
页码:296 / 308
页数:13
相关论文
共 50 条
  • [1] Implementation and Dissemination of a High-Value Care Program at an Academic Safety Net Health System: Impact and Opportunities for Learning Organizations
    Williams, Stephen B.
    McCaffrey, Peter
    Reynoso, David
    Keiser, Phillip
    Trevino, Rick
    Heymann, John
    Doulatram, Gulshan
    DeAnda, Abe
    Harlin, Timothy J.
    Sharma, Gulshan
    JOURNAL OF HEALTHCARE MANAGEMENT, 2023, 68 (06) : 453 - 454
  • [2] Promoting Evidence-Based High-Value Health Care
    Ross, Joseph S.
    JAMA INTERNAL MEDICINE, 2015, 175 (09) : 1564 - 1565
  • [3] Strategies to Promote High-Value, Evidence-Based Pharmaceuticals
    Hauser, Joshua
    Redberg, Rita F.
    JAMA INTERNAL MEDICINE, 2023, 183 (09) : 912 - 913
  • [4] Laboratory Formulary: A Model for High-Value Evidence-Based Medicine
    Zhang, Y. Victoria
    Smoller, Bruce R.
    Levy, Paul C.
    CLINICAL CHEMISTRY, 2017, 63 (07) : 1299 - 1300
  • [5] Management of Low Back Pain: Getting From Evidence-Based Recommendations to High-Value Care
    Atlas, Steven J.
    ANNALS OF INTERNAL MEDICINE, 2017, 166 (07) : 533 - 534
  • [6] Association of Standardization of Continuous Renal Replacement Therapy and High-Value Care: An Evidence-Based Approach
    Tseng, Joshua
    Halbert, Ronald J.
    Minissian, Nareg
    Rodriguez, Hector
    Barathan, Shrinath
    Hain, Patricia
    Alban, Rodrigo F.
    JAMA INTERNAL MEDICINE, 2018, 178 (04) : 572 - +
  • [7] The Four Habits of High-Value Health Care Organizations
    Bohmer, Richard M. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (22): : 2045 - 2047
  • [8] Association of Behavioral Nudges With High-Value Evidence-Based Prescribing in Oncology
    Takvorian, Samuel U.
    Ladage, Vrushabh P.
    Wileyto, E. Paul
    Mace, Drew S.
    Beidas, Rinad S.
    Shulman, Lawrence N.
    Bekelman, Justin E.
    JAMA ONCOLOGY, 2020, 6 (07) : 1104 - +
  • [9] Regional Evidence-Based Practice Fellowship Program: Impact on Evidence-Based Practice Implementation and Barriers
    Kim, Son Chae
    Brown, Caroline E.
    Ecoff, Laurie
    Davidson, Judy E.
    Gallo, Ana-Maria
    Klimpel, Kathy
    Wickline, Mary A.
    CLINICAL NURSING RESEARCH, 2013, 22 (01) : 51 - 69
  • [10] Development and Implementation of Evidence-Based Practice in Cancer Care: Challenges and Opportunities
    So, Winnie K. W.
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2016, 3 (01) : 33 - 36